http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113633661-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ecb892f695140feb442bf15241cdab00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5169
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0006
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
filingDate 2021-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8801659950a3a0e766d04d6e7be96406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8deceb7b3138f60f475f5370095cceae
publicationDate 2021-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113633661-A
titleOfInvention A kind of zeolite composite nanozyme for tumor targeting and its preparation method and application
abstract The invention discloses a zeolite composite nanozyme for tumor targeting, a preparation method and application thereof. 4-7 parts of endoribonuclease, 2-4 parts of endo-deoxyribonuclease, 1-2 parts of human serum albumin, 1-2 parts of glutathione, 2-3 parts of ferrous ammonium sulfate, azine The diammonium salt contrast agent is composed of 1-2 parts, the preparation method of the nano-drug is simple, the number of repeating units can be controlled by polymerization, the dosage ratio and concentration of the two polymers can be adjusted, and the loading amount of the bortezomib drug can be easily adjusted , In addition to chemotherapy by bortezomib, the nano-drug can also perform photothermal therapy and photoacoustic imaging. The synergistic effect of each part provides guidance for real-time diagnosis of tumor treatment process.
priorityDate 2021-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113143959-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425553238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8759
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9Z2E3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID387447
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID856478
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID112442685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517045
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ76MJ5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451859813
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID26918
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11437275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID553551
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449704143
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID42358
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID78943
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2081
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9HDX2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21795
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO33655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419478079
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4932
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO75460
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9EQY0
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124886
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454515022

Total number of triples: 65.